# Different Doses of Colchicine on hsCRP

Study · id `cardio:ct-nct06078904` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06078904](<https://clinicaltrials.gov/study/NCT06078904>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06078904

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT06078904. Randomized; quadruple masking; primary purpose treatment. Start 2023-10-10 (actual); primary completion 2023-12-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT06078904, source copy `cardio:ctgov-nct06078904-2024-04-16`, retrieved 2026-10-26)
- Started: 2023-10-10 (actual) (ClinicalTrials.gov record NCT06078904, source copy `cardio:ctgov-nct06078904-2024-04-16`, retrieved 2026-10-26)
- Primary completion: 2023-12-25 (actual) (ClinicalTrials.gov record NCT06078904, source copy `cardio:ctgov-nct06078904-2024-04-16`, retrieved 2026-10-26)
- Completion: 2024-04-15 (actual) (ClinicalTrials.gov record NCT06078904, source copy `cardio:ctgov-nct06078904-2024-04-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06078904, source copy `cardio:ctgov-nct06078904-2024-04-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06078904-2024-04-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Different Doses of Colchicine on hsCRP
- Condition: Coronary Artery Disease
- Condition: Percutaneous Coronary Intervention
- Intervention (Drug): Colchicine 0.5 MG
- Intervention (Drug): Colchicine 0.375 MG
- Intervention (Drug): Colchicine 0.25 MG
- Intervention (Drug): Placebo
- Lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (`cardio:org-union-hospital-tongji-medical-college-huazhong-university-090806`)

## Provenance

Content hash: 0ad1822f56fa7cb001af96e250e8df0592bca68088d63c60bac1b16ce0c748e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
